These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8121090)
1. [Clinical study of intrapleural administration of pirarubicin (THP-ADM) in the treatment of malignant pleural effusion secondary to lung cancer]. Makimoto T; Hoshino H; Tsuchiya S; Nakano H; Watanabe S; Naruse I; Fueki N; Ezawa K; Takise A; Saitoh R Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1542-7. PubMed ID: 8121090 [TBL] [Abstract][Full Text] [Related]
2. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer]. Gu LJ; Wang WJ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1023-6. PubMed ID: 16864104 [TBL] [Abstract][Full Text] [Related]
3. [Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer]. Saisho S; Saeki T; Takashima S; Aogi K; Ohsumi S Gan To Kagaku Ryoho; 2003 Dec; 30(13):2063-8. PubMed ID: 14712766 [TBL] [Abstract][Full Text] [Related]
4. [Intrapleural administration of pirarubicin in the treatment of malignant pleural effusion]. Gotoh T; Nakamura T; Hiramori N; Fujii T; Fujita Y; Kida T; Arimoto T; Sakai M; Iwasaki Y; Tanaka Y Gan To Kagaku Ryoho; 1991 Sep; 18(12):2121-7. PubMed ID: 1653558 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients]. Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916 [TBL] [Abstract][Full Text] [Related]
6. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion]. Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796 [TBL] [Abstract][Full Text] [Related]
8. [Intrathoracic administration of adriamycin with closed tube thoracostomy drainage for malignant pleuritis: observation on the administration dosage]. Harada J; Yamato K; Aoyama S; Ishii H; Takeyama H; Tokioka M; Osada T; Murakami M; Ueda N Gan To Kagaku Ryoho; 1983 Oct; 10(10):2152-7. PubMed ID: 6312901 [TBL] [Abstract][Full Text] [Related]
9. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer]. Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998 [TBL] [Abstract][Full Text] [Related]
10. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion]. Ishimori S; Okada S; Yamagata S; Satoh S Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817 [TBL] [Abstract][Full Text] [Related]
11. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer. Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208 [TBL] [Abstract][Full Text] [Related]
12. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Stefani A; Natali P; Casali C; Morandi U Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008 [TBL] [Abstract][Full Text] [Related]
13. Primary treatment of malignant pleural effusions: video-assisted thoracoscopic surgery poudrage versus tube thoracostomy. Erickson KV; Yost M; Bynoe R; Almond C; Nottingham J Am Surg; 2002 Nov; 68(11):955-9; discussion 959-60. PubMed ID: 12455787 [TBL] [Abstract][Full Text] [Related]
14. [Pleuritis carcinomatosa]. Miyanaga A; Gemma A Gan To Kagaku Ryoho; 2011 Apr; 38(4):524-7. PubMed ID: 21498978 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion]. Fujii M; Okabe K; Toki H; Fujita Y; Ishimitsu T Gan No Rinsho; 1984 Jul; 30(8):895-8. PubMed ID: 6471394 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694 [TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer. Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism]. Kang M; Zhou L; Lin P Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704 [TBL] [Abstract][Full Text] [Related]
19. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. Seaton KG; Patz EF; Goodman PC AJR Am J Roentgenol; 1995 Mar; 164(3):589-91. PubMed ID: 7532350 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion. Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]